A
Angela Dispenzieri
Researcher at Mayo Clinic
Publications - 1212
Citations - 72269
Angela Dispenzieri is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Multiple myeloma & Amyloidosis. The author has an hindex of 117, co-authored 1107 publications receiving 60367 citations. Previous affiliations of Angela Dispenzieri include University of Rochester & Kyungpook National University Hospital.
Papers
More filters
Journal ArticleDOI
Prognostic Implications of Serum Monoclonal Protein Positivity By Mass-Fix in Bone Marrow Minimal Residual Disease Negative (MRD-) Patients with Multiple Myeloma
Jithma P. Abeykoon,David L. Murray,Isaiah Murray,Dragan Jevremovic,Angela Dispenzieri,Bonnie K. Arendt,Surendra Dasari,Morie A. Gertz,Wilson I. Gonsalves,Wilson I. Gonsalves,Taxiarchis Kourelis,Eli Muchtar,David Dingli,Rahma Warsame,Ronald S. Go,Martha Q. Lacy,Nelson Leung,Francis K. Buadi,Yi Lin,Robert A. Kyle,S. Vincent Rajkumar,Shaji Kumar,Prashant Kapoor +22 more
TL;DR: The prognostic impact of serum Mass-Fix MRD status in multiple myeloma patients who were MRD negative by NGF around day 100 post-ASCT is assessed.
Journal ArticleDOI
Development and Results of a Multiple Myeloma Specific Custom 77-Gene Mutation Panel for Clinical Targeted Sequencing
K. Martin Kortuem,A. Keith Stewart,Laura Ann Bruins,Gregory J. Ahmann,George Vasmatzis,S. Vincent Rajkumar,Shaji Kumar,Angela Dispenzieri,Martha Q. Lacy,Morie A. Gertz,Rafael Fonseca,Mia D. Champion,P. Leif Bergsagel,Esteban Braggio +13 more
TL;DR: A custom gene panel for identification of mutations, copy-number changes and clonal frequency in multiple myeloma (MM) samples and identified a truncating XBP1 mutation in a Pt refractory to bortezomib.
Journal ArticleDOI
Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Myeloma (MM) - Chronic Graft Versus Host Disease (GVHD) is Associated with Lower Risk of Relapse and Superior Progression Free Survival (PFS) - A CIBMTR Analysis.
Parameswaran Hari,A. John Barrett,Smriti Shrestha,Gisela Tunes da Silva,Mei-Jie Zhang,Angela Dispenzieri,Gustavo Milone,Sagar Lonial,Olle Ringdén +8 more
TL;DR: After matched sibling allogeneic HSCT for MM, aGVHD is associated with a higher risk of TRM whereas cGVHD decreases the risk of relapse and improves PFS, and the effect of cGV HD may vary with the type of MM with greater impact in non IgG MM.
Journal ArticleDOI
A Reappraisal of Immunoglobulin Variable Gene Primers and Its Impact on Assessing Clonal Relationships Between PB B Cells and BM Plasma Cells in AL Amyloidosis
Nagaaki Katoh,Tanya L. Poshusta,Michelle K. Manske,Angela Dispenzieri,Morie A. Gertz,Roshini S. Abraham,Marina Ramirez-Alvarado +6 more
TL;DR: Detailed analysis of a larger cohort of AL patients is reported to validate the prior findings and provide important insights into the disparity with the earlier data, including clinical history of the patients and methodological analysis.
Journal ArticleDOI
Trends in Utilization and Outcomes of Autologous Hematopoietic Cell Transplantation (AHCT) in the Upfront Management of Patients with Multiple Myeloma: A Cibmtr Analysis
Luciano J. Costa,Xiaobo Zhong,Mei-Jie Zhang,Sagar Lonial,Amrita Krishnan,Angela Dispenzieri,Parameswaran Hari +6 more
TL;DR: The use of single agent Melphalan conditioning increased from 54% in 1995–1999 to nearly 100% in the latest period concomitant with near disappearance of total body irradiation-based and multi-drug conditioning regimens.